Gingicaine Gel, Mint Julep
Product Images NDC 10129-063

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Gingicaine Gel, Mint Julep (NDC 10129-063). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gingi-pak A Division Of The Belport, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Allergy Alert

This is a warning message for a medical product, it advises not to use the product if the person has a previous history of allergy to any "caine" local anesthetics.*

FDA Label Image

Keep Out Of Reach Of Children (Children Page 001)

This text is a cautionary statement about Gingicaine Gel products advising to keep them out of reach of children and to seek immediate medical attention if a child ingests the product.*

FDA Label Image

Contraindications

This text appears to be a warning about the use of a local anesthetic product. It advises physicians not to use the product in patients who have had an allergic reaction to ester-type local anesthetics, and to avoid using it for teething or in children under 2 years old.*

FDA Label Image

Active Ingredient (Gingicaine Active Ingredients 001)

This is a medication that contains benzocaine as its active ingredient, which is used as an oral anesthetic. It is uncertain what the brand or specific form of the medication is.*

FDA Label Image

Avoid Excessive Heat (Gingicaine Avoid Excessive Heat)

This is a warning to avoid exposing something to temperatures above 40 °C (104 °F) in order to prevent potential damage or danger.*

FDA Label Image

Consult A Doctor Promptly (Gingicaine Consult A Doctor)

FDA Label Image

Dosage And Administration001 (Gingicaine Dosage And Admin 001)

FDA Label Image

Dosage And Administration002 (Gingicaine Dosage And Admin 002)

This text provides guidelines for the use of local anesthetic, cautioning the use of sterile cotton or gauze for applying the anesthetic to mucosa and avoiding cross-contamination between patients. The recommended dosage should not be exceeded, and the anesthetic should remain in place for at least 1 minute before spitting out. This product is indicated for adults and children 2 years of age and older, while children under 2 should consult a dentist or a doctor.*

FDA Label Image

Indications (Gingicaine Indications 001)

This text describes the various uses of anesthesia for the mucous membranes of the oropharynx. It can be used to reduce pain during ulcers, needle punctures, deep scaling procedures, and the application of matrix bands. Additionally, it can assist with impressions or intraoral radiographs of patients who have an excessive gag reflex.*

FDA Label Image

Precautions (Gingicaine Precaution 001)

This text provides precautions for dentists when applying local anesthetics. Dentists are advised to avoid applying them to infected or severely traumatized mucosal areas, or in posterior pharynx regions where protective reflexes could be affected. Additionally, dentists should exercise caution when working with patients who have known drug sensitivities or allergies to ester-type anesthetics. It is advised not to have contact with local anesthetics to prevent possible sensitization.*

FDA Label Image

Uses (Gingicaine Uses 001)

This text describes the uses of a product to reduce pain or discomfort caused by minor dental procedures, minor gum injury, canker sores, sore throat, and minor mouth or gum irritations caused by dentures or orthodontic appliances.*

FDA Label Image

Inactive Ingredient (Inactive Ingredient Page 001)

Polyethylene Glycol 3350 and Polyethylene Glycol 400 are chemical compounds commonly used as laxatives to treat constipation. They work by retaining water in the stool, making it easier to pass. Potassium Sodium Saccharate is not a commonly known compound and it is not possible to provide a useful description based on this text alone.*

FDA Label Image

Mint Julep Jar Label

This is a drug facts label for a topical gel containing 20% Benzocaine, used for oral anesthesia to reduce pain or discomfort caused by minor dental procedures such as canker sores, and sore throat. It warns against usage in case of allergy to ester-type local anesthetics, the risk of methemoglobinemia, and its usage for infants younger than 2 years of age. The doctors or dentists should apply to dry mucosa, and cotton or gauze should be used while applying. If symptoms like pale skin, headache, or rapid heartbeat develop, one should seek immediate medical attention. It should be kept away from children and should not exceed the recommended dosage.*

FDA Label Image

Purpose (Purpose Page 001)

Gingicaine Gel is a topical anesthetic used by dentists before giving injections. It is applied on the patient's gum.*

FDA Label Image

Warnings

This is a warning for a product that should only be used externally. If the product is used improperly, it may cause methemoglobinemia, which is a rare but serious condition. This condition reduces the amount of oxygen carried in blood, and must be treated promptly. If you experience symptoms such as pale, gray, or blue colored skin, headache, rapid heart rate, shortness of breath, dizziness, lightheadedness, fatigue, or lack of energy, you should stop using the product and seek immediate medical attention. Additionally, the product should not be used in children under the age of 2.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.